Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
ASTH Transcript
Astrana Health, Inc. (ASTH) Q4 2025 Earnings Call Transcript
Positive3-2
The earnings call indicates strong financial performance with record-high adjusted EPS and optimistic guidance for 2026 and 2027. The integration of Prospect Health and strategic partnerships are progressing well, and AI tools are enhancing operational efficiency. Despite some concerns about Medicaid disenrollments and management's lack of specific quantifications, the overall sentiment is positive. The expanded partnerships and AI deployment are likely to boost short-term stock price, leading to a positive outlook.
Astrana Health, Inc. (ASTH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Neutral1-13
Astrana Health, Inc. (ASTH) Q3 2025 Earnings Call Transcript
Positive11-6
The earnings call indicates positive sentiment with strong revenue guidance for 2025, optimistic medium-term EBITDA projections, and a strategic partnership with Intermountain Health. Despite a minor EBITDA reduction due to timing delays, the company's focus on deleveraging and synergy savings, along with stable cash flow and improving Medicaid trends, are favorable. The Q&A section did not reveal significant negative concerns, and the partnership and revenue growth are expected to positively impact the stock price.
Astrana Health, Inc. (ASTH) Q2 2025 Earnings Call Transcript
Unknown8-8
The earnings call presents mixed signals. While there are positive aspects like market expansion, breakeven achievements, and optimistic guidance, there are significant concerns such as potential revenue headwinds from Medicaid changes and lack of clarity in management's responses. The company's conservative approach in its guidance and the impact of legislative changes in California also add uncertainty. These factors, combined with the absence of a market cap, suggest a neutral stock price movement in the short term.
ASTH Slides
ASTH Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
